跳至主要内容
临床试验/NCT00461357
NCT00461357Unknown不适用

Outcome After Renal Transplantation of a Randomized Prospective Trial in the Eurotransplant Senior Program

Medical University of Vienna0 个研究点目标入组 48 人开始时间: 2003年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
48

研究概览

简要总结

The Eurotransplant Senior Program (ESP) started in 1999 with local allocation of kidneys from deceased donors elder than 65 years to recipients elder than 65 years. The requirements for immunosuppression in this group of patients are high due to the large amount of comorbidities.

This prospective randomized trial compared the standard immunosuppressive protocol based on cyclosporine A (CyA) used at our center within the ESP, to a calcineurin inhibitor-free protocol based on sirolimus (SRL).

The aim of this study is to investigate the effect of a CNI-free therapy on the function of elderly kidneys 6 months post transplantation, measured by GFR.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Recipients of the Eurotransplant Senior Program
  • negative cytotoxic crossmatch
  • signed informed consent

排除标准

  • High sensitized recipients (PRA > 40%)
  • Non heart Beating Donor
  • Hyperlipidemia
  • Leucocytopenia (< 3000/mm3)
  • Thrombocytopenia (< 75000/mm3)

研究者

申办方类型
Other

相似试验

Sirolimus Based Immunosuppression for Patients... | 临床试验